Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment

Globally, cervical cancer is the fourth leading cancer among women and is dominant in resource-poor settings in its occurrence and mortality. This study focuses on developing liquid immunogenic fiducial eluter (LIFE) Biomaterial with components that include biodegradable polymers, nanoparticles, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2024-03, Vol.16 (6), p.1212
Hauptverfasser:	Moreau, Michele, Keno, Lensa S, China, Debarghya, Mao, Serena, Acter, Shahinur, Sy, Gnagna, Hooshangnejad, Hamed, Chow, Kwok Fan, Sajo, Erno, Walker, Jacques, Oh, Philmo, Broyles, Eric, Ding, Kai, Viswanathan, Akila, Ngwa, Wilfred
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological products Biomaterials Cadavers Cancer Cancer therapies Care and treatment CD40 antigen Cervical cancer Cloning Computed tomography CT imaging Disease control Ethylenediaminetetraacetic acid FDA approval Females Health aspects Human papillomavirus Hydrogels Immune response Immunization Immunogenicity Investigations Magnetic resonance imaging Metastases Mice Nanoparticles Pharmacodynamics Quality of life Radiation therapy Radiotherapy Survival Survival analysis Toxicity Tumors Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!